+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction



Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction



CytoTherapy 16(9): 1229-1237



Endothelial progenitor cells (EPCs) are known to play a beneficial role by promoting postnatal vasculogenesis in pathological events, such as ischemic heart disease and peripheral artery disease. However, little is known about the potential of EPCs to restore heart damage tissue. We compared the cardiac differentiation capacity of EPCs isolated from peripheral blood of patients with acute myocardial infarction (AMI) with EPCs obtained from umbilical cord blood (UCB). EPCs from both origins were isolated by density gradient centrifugation and characterized through the use of endothelial markers (UEA-1lectin, CD133 and KDR) and endothelial cell colony-forming unit assay. Cardiac differentiation capacity of EPCs was assessed by immunofluorescence and reverse transcriptase-polymerase chain reaction after 5-azacytidine (5-aza) induction. No significant differences were observed between the number of endothelial cell colony-forming units in peripheral blood of patients with AMI and samples from UCB. Moreover, 5-aza induced the appearance of myotube-like structures and the positive expression of sarcomeric α-actinin, cardiac troponin I and T and desmin in a similar pattern for both cell sources, which indicates a comparable acquisition of a cardiac-like phenotype. For the first time, we have compared, in vitro, the cardiomyogenic potential of EPCs derived from patients with AMI with UCB-derived EPCs. Our data indicate that EPCs obtained from both origins have similar plasticity and functions and suggest a potential therapeutic efficacy in cardiac cell therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051944951

Download citation: RISBibTeXText

PMID: 24969968

DOI: 10.1016/j.jcyt.2014.05.012


Related references

Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Research in Cardiology 99(1): 61-68, 2004

Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions. American Journal of Therapeutics 19(1): 44-50, 2012

Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells and Development 21(13): 2457-2470, 2012

Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin. Febs Letters 579(27): 6060-6066, 2005

Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. Journal of Biological Chemistry 280(17): 16838-16842, 2005

Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. International Journal of Cardiology 130(3): 457-462, 2008

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103(23): 2776-2779, 2001

No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non- ST -Segment-Elevation Myocardial Infarction. Journal of the American Heart Association 7(19): E009444, 2018

Endothelial progenitor cells in diabetic patients with myocardial infarction - can statins improve their function?. European Journal of Pharmacology 741: 25-36, 2014

Ex vivo Akt/HO-1 gene therapy to human endothelial progenitor cells enhances myocardial infarction recovery. Cell Transplantation 21(7): 1443-1461, 2012

Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. Journal of Vascular Research 42(5): 408-414, 2005

Cardiomyogenic differentiation potential of human adipose precursor cells. International Journal of Cardiology 133(3): 399-401, 2009

Endothelial progenitor cells related gene expression changes before and early after revascularization in patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 34(7): 620-624, 2006

Endothelial progenitor cell miR-126 promotes homing of endothelial progenitor cells within arterial thrombus in patients with cerebral infarction and its molecular mechanism. European Review for Medical and Pharmacological Sciences 22(4): 1078-1083, 2018

Resident Endothelial Progenitor Cells From Human Placenta Have Greater Vasculogenic Potential Than Circulating Endothelial Progenitor Cells From Umbilical Cord Blood. Cell Medicine 2(3): 85-96, 2012